成功的活体捐赠者肝脏移植从捐赠者与低威尔布兰德因子活动:一个案例报告
Takahiko Omameuda1, Taiichi Wakiya1, Yasunaru Sakuma1
1Division of Gastroenterological, General and Transplant Surgery, Department of Surgery, Jichi Medical University, Shimotsuke city, Tochigi, Japan.
Transplantation proceedings
|August 13, 2025
概括
活体捐赠者的肝移植是安全的,即使捐赠者具有低威尔布兰德因子 (VWF) 活性. 仔细的术后管理确保了供体安全和接受者的稳定血静,影响了供体资格标准.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 移植手术 移植手术
- 血液学 血液学 血液学
背景情况:
- 由于安全问题,具有威尔布兰德因子 (VWF) 异常的捐赠者很少被考虑进行肝移植.
- 低VWF活性,常见且往往无症状,对活体供体肝移植 (LDLT) 的影响表征不佳.
研究的目的:
- 报告一个成功的LDLT病例从一个边界低VWF活动的捐赠者.
- 在捐赠者和接受者中详细介绍术后和长期凝血概况.
- 评估低捐助者VWF活动对接受者的血液静止的影响.
主要方法:
- 来自具有轻微降低VWF活性的供体的LDLT病例报告.
- 在外科期间进行VWF/FVIII缩剂输注和监测.
- 在随访期间对捐赠者和接受者进行全面的凝血分析.
主要成果:
- 通过外科手术期间的VWF替代成功进行了LDLT;捐赠者没有出现并发症.
- 捐赠者的VWF参数在术后正常化,表明长期保持血静.
- 接收者在移植后保持稳定的VWF相关的凝血参数.
结论:
- 来自低VWF水平的捐赠者的LDLT在适当的术后管理下是安全的.
- 低捐助者VWF活性不一定会影响接受者的血液静止.
- 这些发现支持对LDLT的经过修订的供体资格评估.
相关概念视频
Kidney Transplant I: Introduction
60
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
60
Tissue Transplantation
519
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
519


